Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Joseph A. Bovi MD
Professor
Department of Radiation Oncology

OFFICE ADDRESS:
Froedtert Specialty Clinics
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
07/1994 - 06/1998 BA, Augustana College, Rock Island, IL
07/1998 - 06/2002 MD, Loyola University Stritch School of Medicine, Maywood, IL

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/2002 - 06/2003 Internal Medicine, Medical College of Wisconsin, Milwaukee, WI
07/2003 - 06/2007 Residency, Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI

FACULTY APPOINTMENTS:
07/01/2007 - 06/30/2008 Instructor, Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
07/01/2008 - 06/30/2014 Assistant Professor, Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
07/01/2014 - 06/30/2020 Associate Professor, Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
07/01/2020 - Present Professor, Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI
07/01/2020 - Present Professor, Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
2009 - Present Department Chair, Department of Radiation Oncology, Community Memorial Hospital, WI
01/2012 - Present Medical Director and Chairman, Radiation Oncology, Community Memorial Hospital, WI
07/01/2020 - Present Vice Chair Safety Committee, Radiation Oncology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226

HOSPITAL STAFF PRIVILEGES:
07/2007 - Present Consulting Staff, Froedtert Hospital, Milwaukee, WI
07/2007 - Present Consulting Staff, Community Memorial Hospital, Menomonee Falls, WI
07/2007 - 07/2018 Consulting Staff, Clement Zablocki Veterans Administration, Milwaukee, WI
07/2007 - Present Courtesy Privileges, Children's Hospital of Wisconsin, Milwaukee, WI
07/2009 - Present Consulting Staff, Froedtert Health, St. Joseph's Hospital, West Bend WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Radiology (ABR)(Therapeutic Radiology)
06/02/2008
12/31/2030
 
Licensure
Number Issue DateExpiration
State of Wisconsin
46147-20
10/31/2007
10/31/2019
 

AWARDS AND HONORS:
1997 Student Laureate Award of the Lincoln Academy of Illinois
1997 Omicron Delta Kappa National Honor Society
1998 Inducted-Phi Beta Kappa
1998 Inducted-Mortar Board National Honor Society
1998 Inducted-Beta Beta Beta Biological Honor Society
2001 Inducted Alpha Sigma Nu Jesuit Honor Society
2001 Nominee for the Geoffrey Gunnar Memorial Scholarship
2002 Inducted-Alpha Omega Alpha
2011 Best Doctors in America
2011 - 2012 MCW's Outstanding Medical Student Teacher, Medical College of Wisconsin
2012 Best Doctors in America
2013 Best Doctors in America
2014 Best Doctors in America
2015 Best Doctors in America
2015 T. Michael Bolger Standing Ovation Award
2016 Recognized as a "Shining Star", Froedtert and Medical College Excellence in Action Program
2016 Best Doctors in America
09/12/2017 - Present Innovator's Award, Medical College of Wisconsin
2017 Best Doctors in America
10/24/2018 Magnanimous Mentors of MCW, Medical College of Wisconsin
2018 Best Doctors in America
2019 Volunteer Service, ABR
2019 Best Doctors in America
2020 Best Doctors in America

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2002 - Present American Society of Therapeutic Radiology and Oncology
2002 - Present American Medical Association
2002 - Present Wisconsin Medical Society
2002 - Present American College of Radiology (ACR)
2008 - Present Leksell Gamma Knife Society
2008 - Present Society for Neuro Oncology

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
09/2015 - Present Frontiers in Radiation Oncology
01/01/2017 - Present Neurosurgery
01/01/2017 - Present Neuro-Oncology
11/01/2018 - Present ABR Board Item Writer/Reviewer

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
08/2009 - Present SEWCC, Southeastern Wisconsin Cancer Conference

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2007 - Present RTOG/NRG Member Brain Committee
08/2010 - 08/2015 Medical Dosimetry Certification Board - American College of Radiology Liaison
03/2013 - 07/01/2018 American College of Radiology Safety and Quality Site Surveyor through the Radiation Oncology Program Accreditation (ROPA)
07/2015 - Present Quality Assurance Review Team for NRG CC001 Protocol
09/2015 - Present Multidisciplinary QA Subcommittee, ASTRO
12/01/2016 - Present Writer, ABR Board Examination Committee, American Board of Radiology
05/09/2018 - Present Member, National Epic Radiation Oncology Steering Board, Epic Systems; Verona, WI
07/01/2018 - Present APEx Surveyor, APEx, ASTRO
08/01/2018 - Present Participant, ABR’s Online Longitudinal Assessment (OLA), ABR
2018 - Present Member, Epic Systems National Radiation Oncology Steering Committee, Invited to participate to conceptualize and assist in the build of radiation oncology workflows within the Electronic Medical Record. Epic Systems; Verona, WI

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Phase II/III Study of Image Guided Radiosurgery/SBRT for Localized Spine Metastasis
Source:
RTOG 0631
Role:
Institutional PI
Dates:
10/14/2009 - Present
 
Title:
Phase III Intergroup Study of Radiotherapy Versus Temozolomide Alone Versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with Newly Diagnosed Anaplastic Oligodendroglioma or Anaplastic Mixed Glioma with Chromosomal Co-deletions of 1p and 19q
Source:
NCCTG: N0577
Role:
Institutional PI
Dates:
05/11/2010 - Present
 
Title:
Randomized Phase II Double-Blind Placebo Controlled Trial of Conventional Chemoradiation and Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation and Adjuvant Temozolomide Plus Placebo in Patients with Newly Diagnosed Glioblastoma
Source:
RTOG 0837
Role:
Institutional PI
Dates:
05/25/2011 - Present
 
Title:
N107C, A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease
Source:
Alliance for Clinic Trials in Oncology
Role:
Institutional PI
Dates:
07/08/2011 - Present
 
Title:
Re-Irradiation of Recurrent Glioma, MCW Experience
Role:
Institutional PI
Dates:
07/29/2011 - Present
 
Title:
Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma
Source:
RTOG 1114
Role:
NATIONAL PI
Dates:
10/25/2011 - Present
 
Title:
NRG CC003 Phase III Trial of Prophylactic Cranial Radiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Source:
NRG CC003
Role:
NATIONAL Imaging Co-Chair
Dates:
2013 - Present
 
Title:
NRG-CC001 A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients with Brain Metastases
Source:
NRG
Role:
NATIONAL Imaging Co-Chair
Dates:
09/01/2015 - Present
 
Title:
A Phase II Study of MRI Based Pre-Operative Accelerated Partial Breast Irradiation
Source:
Cancer Center
Dates:
12/01/2015 - 11/30/2017
 
Title:
Innovator's Award: Brain Met Application
Source:
Medical College of Wisconsin
Role:
Developer
Dates:
09/12/2017 - Present
Direct Funds:
$20,000 (Annually for five years)
 
Title:
Consulting Services Agreement
Source:
Elekta, Inc.
Role:
Institutional PI
Dates:
04/15/2019 - 12/31/2019
 
Title:
Biomarkers for Prediction of Radiation-induced Neurocognitive Toxicity
Source:
NRG Oncology Foundation, Inc/NIH NCI
Role:
MCW Subcontract
Dates:
10/01/2019 - 09/30/2020
Direct Funds:
$79,633
 
Title:
CC009 National Imaging Phase III Trial of Stereotactic Radiosurgery (SRS) Versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or fewer Brain Metastases from SCLC
Role:
PI
PI:
Bovi, J
 
Title:
BN 009 National Imaging Phase III Trail of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for First or Second Distant Brain Relapse After Upfront SRS with Brain Metastases Velocity >/= 4 Brain Metastases/Year
Role:
PI
PI:
Bovi, J
 
Non-Peer Review
Title:
Predictors of Cognitive Outcome Following Whole Brain Radiation. A Diffusion Tensor and MRI Volumetric Study
Source:
Folkman Grant, Medical College of Wisconsin, Department of Radiation Oncology, Stimulus Program
Role:
PI
Dates:
07/2010 - 07/2011
Direct Funds:
$25,000
 
Title:
Foxconn Smart Cities Smart Futures Competition Grand Prize Winner
Source:
Foxconn
Role:
PI
Dates:
12/2019
Direct Funds:
$7,500
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
The Use of MR of Enhanced Ventilation-Perfusion Imaging as a Predictor of Radiation Pneumonitis, Radiation Oncology Grand Rounds, 2004
Comparison of 3 Partial Breast Irradiation Techniques: Treatment Effectiveness Based Upon Biological Models, Radiation Oncology Grand Rounds, 2005
Toxicity and Cosmetic Outcome from Multi-Catheter Accelerated Partial Breast Irradiation in Early Stage Breast Cancer Patients, Radiation Oncology Grand Rounds, 2006
Glioblastoma Multiforme, Radiation Oncology Grand Rounds, 2008
Stereotactic Spine XRT, Radiation Oncology Grand Rounds, 02/2010
Palliative Care Lecture, Clinical Cancer Center, Froedtert & the Medical College of Wisconsin, 05/2010
Radiation Therapy for Head and Neck Malignancy, ENT Grand Rounds, 06/2010
Cognitive Outcomes Following Whole Brain Radiation, Radiation Oncology Grand Rounds, 06/2010
Palliative Care Lecture, Clinical Cancer Center, Froedtert & the Medical College of Wisconsin, 02/2011
Radiation Therapy and CNS Disease, Neurosurgery Grand Rounds, 04/2011
Radiation Therapy for Pituitary Disease, Endocrine Grand Rounds, 05/2011
CNS Toxicity of Radiation Therapy to Brain Metastases, Radiation Oncology Grand Rounds, 10/2012
Palliative Care Lecture, Clinical Cancer Center, Froedtert & the Medical College of Wisconsin, 12/2012
Ophthalmology of Systemic Diseases, Radiation in Graves Disease, 10/2013
New Frontiers in Neuro-Oncology, Radiation Oncology Grand Rounds, 10/2014
Palliative Care Lecture, Clinical Cancer Center, Froedtert & the Medical College of Wisconsin, 12/2014
Updates in Neuro-Oncology, Neurosurgery Grand Rounds, 03/2015
Updates in Stereotactic Spine Radiotherapy, Sarcoma Research Conference, Medical College of Wisconsin, 04/2015
Palliative Care Lecture, Clinical Cancer Center, Froedtert & the Medical College of Wisconsin, Milwaukee, WI, 12/2015
CNS, Radiation Oncology Grand Rounds, Froedtert & the Medical College of Wisconsin, 04/13/2016
Palliative Care Lecture, Clinical Cancer Center, Froedtert & the Medical College of Wisconsin, Milwaukee, WI, 12/2016
Gamma Knife for Neurosurgeons Grand Rounds, Medical College of Wisconsin, 03/17/2017
Radiation Oncology Grand Rounds: "Daring to Consider an Institutional Guideline for Management of Brain Metastasis", Medical College of Wisconsin, 04/17/2017
Palliative Care Lecture, Clinical Cancer Center, Froedtert & the Medical College of Wisconsin, Milwaukee, WI, 06/2017
Bovi, JA, Radiation Oncology, MCW Medical Student Subspecialty Dinner Information Session, Medical College of Wisconsin, 03/27/2018
Metastatic CNS Updates, Radiation Oncology Grand Rounds, Froedtert and Medical College of Wisconsin, 04/11/2018
Bovi, J, Hippocampal Avoidant WBRT Bench to Bedside to Beam, OIG Lunch, Medical Education Building, 05/01/2019
Bovi, JA, Palliative via Radiation Therapy, Palliative Care Fellowship Core Curriculum, Froedtert Hospital, 12/18/2019
Bovi, J, Palliative Care Practicum, SPARCC, Virtual, 07/24/2020
 
Regional
Comparison of 3 Partial Breast Irradiation Techniques: Treatment Effectiveness Based Upon Biological Models, Wisconsin Society of Radiation Oncology Annual Meeting, 04/2005
GYRO Club Lecture, Stereotactic Radiotherapy, Milwaukee, WI, 03/2010
Stereotactic Body Radiation Therapy, Medical Education Program, Community Memorial Hospital, 12/2011
Introduction to Radiology, Concordia University Physician Assistant School, Milwaukee, WI, 10/2013
Introduction to Radiology, Concordia University Physician Assistant School, Milwaukee, WI, 10/2014
Third Annual Advances in Hematology and Oncology, New Frontiers in Neuro Oncology, Green Bay, WI, 10/2014
Introduction to Radiology, Concordia University Physician Assistant School, Milwaukee, WI, 10/2015
Fourth Annual Advances in Hematology/Oncology, New Frontiers in Neuro Oncology, Green Bay, WI., 10/2015
Updates in Neuro-Oncology, Community Memorial Hospital, 11/30/2015
Introduction to Radiology, Concordia University Physician Assistant School, Milwaukee, WI, 10/2016
Bovi, Joseph, New Technologies for Brain Metastases, RTOW Lecture, Froedtert and the Medical College of Wisconsin, 11/04/2017
Outcomes after Gamma Knife Radiosurgery for Acoustic Neuroma, Lecture, UW-Milwaukee, 03/07/2019
Bovi, JA, Caring for Cancer: An Individualized Approach with a Network of Solutions, Community Memorial Foundation President's Council, Menomonee Falls, WI, 05/14/2019
Bovi, J, Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL)., ASCO Annual Meeting, Virtual, 11/30/2020
 
National
Adaptive Radiation Therapy (ART) Forum - Image Guidance in Clinical Practice, ASTRO 2007 Annual Meeting, Los Angeles CA, 10/27/2007
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With and Without Hippocampal Avoidance in Patients with Brain Metastases, Provided a description of the predeictive imaging biomarkers to be considered in NRG Oncology CC001. NRG 2015 Annual Meeting, San Diego, CA, 02/2014
Radiation Oncology Systems Integration, Froedtert Health & the Medical College of Wisconsin, Oncology Focus Group, Epic Campus, Verona, WI, 03/2015
NRG-CC03: Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer, Provided a description of the predictive imaging biomarkers to be considered in NRG Oncology CC003. NRG Meeting, Denver, CO, 07/2015
Whole Brain Radiotherapy Reconsidered, Chicago Radiological Society, CRS Education Program Series, Chicago, IL, 04/21/2016
Advances in Neuro-Oncology, Given as part of a visiting professor lecture. Loyola University, Grand Rounds, Maywood, IL, 04/22/2016
BOVI, JA, Pretreatment volume of MRI-determined white matter injury (WMI) predicts cognitive decline after hippocampal avoidant (HA) WBRT for brain metastases: Secondary analysis of NRG Oncology RTOG 0933, Society for NeuroOncology, San Francisco, CA, 11/18/2017
ASTRO Safety Panel, American Society for Radiation Oncology Annual Conference, San Antonio, TX, 10/22/2018
Elekta Gamma Knife Icon, American Society for Radiation Oncology Annual Conference, San Antonio, TX, 10/22/2018
Bovi, JA, The Value of Compassion Fatigue in the Physician Patient Relationship, Ethics Grand Rounds Unity Point, Rock Island, IL, 05/08/2019
Bovi, JA, Mitigating the Cognitive Effects of Whole Brain Radiotherapy in Patients with Brain Metastases, Neuro-Psychology Senior Seminar, Augustana College, IL, 05/09/2019
Pretreatment volume of MRI-determined white matter injury (WMI) predicts cognitive decline after hippocampal avoidant (HA) WBRT for brain metastases: Secondary analysis of NRG Oncology RTOG 0933, Society for NeuroOncology Brain Mets Symposium, New York, New York, 08/16/2019
 
International
Bovi, J, Triple Aim in SRS Webinar", July 7th: A Neurosurgeon's Perspective (McDermott) & Radiation Oncologist's Perspective, Elekta Webinar, Virtual, 07/07/2020
 

COMMITTEE SERVICE:
Medical College of Wisconsin
2003 - 2011 Interview and Make Recommendations to the Committee on Potential Medical School Applicants, Medical College of Wisconsin
09/2006 Reviewed the Craniofacial Surgery Fellowship Program and Made Recommendations for Improvement to the Graduate Medical Education Council, Medical College of Wisconsin
2006 - 2016 Education Committee, Radiation Oncology Department
2009 - Present Safety and Quality Subcommittee, Radiation Oncology Department
2010 - 2018 Medical Physics Residency Program Director
2011 - 07/2013 Compensation Committee, Radiation Oncology Department
2013 - Present Neuro-Oncology Faculty Research Chair, Froedtert & Medical College of Wisconsin Cancer Center Clinical Program Leadership
2014 - Present Member, MCW Disaster Med Panel, Medical College of Wisconsin
 
Hospital
2007 - 2008 Epic (electronic medical record) Implementation Committee
2008 - Present Cancer Center Working Group
2008 - Present Cancer Care Committee (Community Memorial Hospital)
2008 - Present Executive Committee (Community Memorial Hospital)
12/01/2011 - 12/01/2014 Radiation Safety Committee (RSC), Medical College of Wisconsin/Froedtert Hospital
2012 - Present Member, Radiation Oncology Operations Committee
2012 - 2013 Member at Large, Medical Executive Council, Froedtert Health/Community Memorial Hospital
2013 - Present Lead Neuro-Oncology Representative, Froedtert & the Medical College of Wisconsin Cancer Center Clinical Program Leadership
2013 - Present Chair, National Accreditation Program for Breast Center Steering Committee, Achieved full accreditation August 2013; August 2016; August 2019
01/2014 - Present Epic (electronic medical record) Cancer Center IT Service Line, Froedtert and the Medical College of Wisconsin
01/2014 - Present Epic (electronic medical record) Stake Holders Committee, Froedtert and the Medical College of Wisconsin
07/01/2015 - Present RadOnc Member, Epic Radiation Oncology Steering Committee
02/01/2017 - Present Epic Physician Builder
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
10/2007 Clinical Examination and Reasoning Course, Head and Neck Exam and General Lymphatics
2007 - Present Radiation Therapy Student Lecture Series
10/2008 Clinical Examination and Reasoning Course, Head and Neck Exam and General Lymphatics
08/2009 - 2013 GURU First Year Medical Student Mentoring Program
10/2009 Clinical Examination and Reasoning Course, Head and Neck Exam and General Lymphatics
2009 - 2013 H&P Preceptor with Recruited Patients for M2's
2009 - Present Clinical Pathways Advisor
10/2010 Clinical Examination and Reasoning Course, Head and Neck Exam and General Lymphatics
10/2011 Clinical Examination and Reasoning Course, Head and Neck Exam and General Lymphatics
10/2012 Clinical Examination and Reasoning Course, Head and Neck Exam and General Lymphatics
2012 - Present Discovery Curriculum, Neuro-Psych Unit Yearly Lecture/Brain Tumors
2013 - Present Clinical Apprenticeship for Medical Students
07/01/2020 - 06/30/2021 Megan Orr
 
Resident and Fellow Education
07/2007 - 07/2016 Coordinator of Visiting Professor Lecture Series (Grand Rounds Didactic)
04/2008 Palliative Care Fellows Core Curriculum Conference
04/2009 Palliative Care Fellows Core Curriculum Conference
12/2009 Palliative Radiation Oncology, Palliative Care Fellowship Lecture Series
2009 - Present Physics Residency Program
04/2010 Palliative Care Fellows Core Curriculum Conference
12/2010 Palliative Radiation Oncology, Palliative Care Fellowship Lecture Series
12/2011 Palliative Radiation Oncology, Palliative Care Fellowship Lecture Series
12/2012 Palliative Care Fellows Core Curriculum Conference
04/2013 Palliative Care Fellows Core Curriculum Conference
12/2013 Palliative Radiation Oncology, Palliative Care Fellowship Lecture Series
04/2014 Palliative Care Fellows Core Curriculum Conference
12/2014 Palliative Radiation Oncology, Palliative Care Fellowship Lecture Series
04/2015 Palliative Care Fellows Core Curriculum Conference
12/2015 Palliative Radiation Oncology, Palliative Care Fellowship Lecture Series
04/2016 Palliative Care Fellows Core Curriculum Conference
10/2016 Palliative Radiation Oncology, Palliative Care Fellowship Lecture Series
04/2017 Palliative Care Fellows Core Curriculum Conference
07/2017 Palliative Radiation Oncology, Palliative Care Fellowship Lecture Series
12/2018 Palliative Care Fellows Core Curriculum Conference
 

EXTRAMURAL TEACHING:
Community/Lay Public
04/2015 - 05/2015 Concordia College of Wisconsin, Physician Assistant Mentor
10/28/2016 Concordia Univerisity, Intro to CT, MRI, US, and PET
10/20/2017 Concordia Univerisity, Intro to CT, MRI, US, and PET
10/2018 Concordia University, Intro to CT, MRI, US, and PET
10/2019 Concordia University, Intro to CT, MRI, US, and PET
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Residents
Elson, Andrew, Medical College of Wisconsin, 04/2013 Research Abstract, Elson A, BOVI J, Kaur K, Maas D, Sinson G, Schultz C. Effect of Treatment Modality on the Hypothalamic-Pituitary Function of Patients Treated with Radiation Therapy for Pituitary Adenomas; Effect of Hypothalamic Dose on Endocrine Outcomes. Podium presentation at the 95th Annual Meeting of ARS, April 2013, Phoenix AZ
Elson, Andrew, Medical College of Wisconsin, 2014 Research Publication, Elson A, Bovi J, Kaur K, Maas D, Sinson G, Schultz C. Effect of treatment modality on the hypothalamic-pituitary function of patients treated with radiation therapy for pituitary adenomas: hypothalamic dose and endocrine outcomes. Front Oncol. 2014;4:73. PMCID: PMC3988389
Straza, Michael, Medical College of Wisconsin, 03/2015 Research Abstract, Straza M, Garcia G, Hariri B, Patel R, Schultz C, Friedland D, BOVI J. Gamma Knife Radiosurgery for Vestibular Schwannoma: Assessment of Quality and Outcomes. Poster presented at the Medical College of Wisconsin, Cancer Center Scientific Retreat, March 20, 2015. (MCWAH RESIDENT RESEARCH AWARD)
Elson, Andrew, Medical College of Wisconsin, 05/2015 Research Publication, Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS. Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. J Neurooncol. 2015 May;123(1):179-88.
Elson, Andrew, Medical College of Wisconsin, 05/2015 Research Publication, Elson A, Bovi J, Siker M, Schultz C, Paulson E. Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma. J Neurooncol. 2015 May;122(3):549-58.
Elson, Andrew, Medical College of Wisconsin, 2015 Research Publication, Elson A, Walker A, Bovi JA, Schultz C. Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting. Front Oncol. 2015;5:27. PMCID: PMC4321406
Sparks, Irina, Medical College of Wisconsin, 03/2017 Research Publication, Bovi, J; Sparks, I; Radiation Therapy in the Prevention of Brain Metastases, March, 2017, Medical Research Archives. Vol5, Issue 3 In Publication
Sparks, Irina, Medical College of Wisconsin, 2017 Research Publication, Prior P, Sparks I, Wilson JF, Bovi J, Currey A, Bradley J, Kelly T, Li XA, White JR. Use of three dimensional conformal radiation therapy for node positive breast cancer does not result in excess lung and heart irradiation. Intl Jrnl of Med Physics, Clinical Engineering and Rad Onc, 2017;6:1-9
Retzlaff, Amber, Medical College of Wisconsin, 2018 Research Publication, A Phase II Study Analyzing Pre-Operative Stereotactic Radiosurgery With Gamma KnifeⓇ IconTM for Brain Metastases.
 
Faculty
Colin Gibson, Medical College of Wisconsin, 05/21/2019 - 05/22/2019 Clinical Workflow and Procedural Visit
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
High School Students
Community Memorial Hospital, 07/2016 - Present Oncology Interest Program
Justin Forbes, Community Memorial Hospital, 06/19/2017 - 08/17/2017 Shadowing & Career Mentorship
 

PROGRAMMATIC DEVELOPMENTS:
 
 
Clinical Programs
2017 - Present Brain Metastases Program
 
 

COMMUNITY SERVICE ACTIVITIES:
10/2009 Breast Cancer Support Group, Community Memorial Hospital, Menomonee Falls, WI
10/2010 Brain Tumor Support Group, Froedtert & the Medical College of Wisconsin, Milwaukee, WI
05/21/2011 Coordinator of Froedtert Hospital Team, Strain for the Brain, Milwaukee, WI
10/2011 Brain Tumor Support Group, Froedtert & the Medical College of Wisconsin, Milwaukee, WI
07/2012 - 07/2014 Underwood Elementary School PTA Treasurer, Wauwatosa, WI
10/2012 Brain Tumor Support Group, Froedtert & the Medical College of Wisconsin, Milwaukee, WI
2013 - Present Coach, Wauwatosa West Junior Trojan Baseball Club
08/2016 Metastatic Breast Cancer Support Group, Froedtert & the Medical College of Wisconsin, Milwaukee, WI
12/05/2016 Coding Volunteer; Underwood Elementary School; Wauwatosa, WI
07/2017 - 07/2019 Underwood Elementary School PTA Treasurer, Wauwatosa, WI
09/29/2017 Fire Fly Flash Run; PTA Charity Organizer; Underwood Elementary; Wauwatosa, WI
 

SPECIAL TRAINING:
03/2008 Leksell Gamma Knife - Principles of Gamma Knife Radiosurgery, Pittsburgh PA
09/2009 Leksell Gamma Knife - Principles and Practices of Gamma Knife Radiosurgery training for Model C, Pittsburgh PA
01/2013 - 04/2013 Crucial Conversations Course, Medical College of Wisconsin, Milwaukee, WI
04/2015 Leksell Gamma Knife Perfexion On-Site Training, Froedtert Hospital, Milwaukee, WI
05/2015 Gamma Knife Radiosurgery Perfexion Training Program, Pittsburgh PA
01/17/2017 - 01/19/2017 Epic Physician's Builder Basic, EPIC, Verona, WI
01/30/2017 - 02/01/2017 Epic Physician's Builder Advanced, EPIC, Verona, WI
03/09/2017 - Present ROI Item Writing, ABR, Tuscon, AZ
03/14/2017 - 03/16/2017 ICON Gamma Knife Training, Pittsburgh, PA
08/29/2017 - 03/14/2018 MCW Leadership Academy in Collaboration with UW-Milwaukee, Lubar School of Business


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Dubner S, BOVI JA, White J, Susnik B. Post-Irradiation Morphea in a Breast Cancer Patient. The Breast Journal 12 (2):173-6, 2006.
2. Bovi J, Qi XS, White J, Li XA. Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models. Radiother Oncol. 2007 Sep;84(3):226-32.
3. BOVI JA, Qi XS, White J, Li XA. Comparison of Three Accelerated Partial Breast Irradiation Techniques: Treatment Effectiveness Based Upon Biological Models. Radiotherapy and Oncology 2007;84:226-232.
4. Schultz CJ, BOVI JA. Current Management of Primary Central Nervous System Lymphoma. International Journal of Radiation Oncology Biology Physics 2010;75:666-678.
5. Wackym PA, Runge-Samuelson CL, Nash JJ, Hannley MT, Poetker DM, Albano K, BOVI JA, Michel MA, Friedland DR, Z Yr, Hannley MT. Gamma Knife Surgery of Vestibular Schwannomas: Volumetric Dosimetry Correlations to Hearing Loss Suggest Stria Vascularis Devascularization as the Mechanism of Early Hearing Loss. Otology & Neurotology 2010 Dec:31 (9):1480-1487.
6. Wackym PA, Runge-Samuelson CL, Nash JJ, Poetker DM, Albano K, Bovi J, Michel MA, Friedland DR, Zhu YR, Hannley MT. Gamma knife surgery of vestibular schwannomas: volumetric dosimetry correlations to hearing loss suggest stria vascularis devascularization as the mechanism of early hearing loss. Otol Neurotol. 2010 Dec;31(9):1480-7.
7. Bovi JA, White J. Radiation therapy in the prevention of brain metastases. Curr Oncol Rep. 2012 Feb;14(1):55-62.
8. Sabsevitz DS, Bovi JA, Leo PD, Laviolette PS, Rand SD, Mueller WM, Schultz CJ. The role of pre-treatment white matter abnormalities in developing white matter changes following whole brain radiation: a volumetric study. J Neurooncol. 2013 Sep;114(3):291-7.
9. Elson A, Bovi J, Kaur K, Maas D, Sinson G, Schultz C. Effect of treatment modality on the hypothalamic-pituitary function of patients treated with radiation therapy for pituitary adenomas: hypothalamic dose and endocrine outcomes. Front Oncol. 2014;4:73. PMCID: PMC3988389
10. LaViolette PS, Mickevicius NJ, Cochran EJ, Rand SD, Connelly J, Bovi JA, Malkin MG, Mueller WM, Schmainda KM. Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma. Neuro Oncol. 2014 Dec;16(12):1599-606. PMCID: PMC4232087
11. Rogers L, Zhang P, Vogelbaum M, Perry A, Ashby L, Modi J, Alleman A, Galvin J, Brachman D, Jenrette J, DeGroot J, BOVI, JA, Werner-Wasik M, Knisely P, and Mehta M. Pathology Concordance Levels For Meningioma Classification and Grading in RTOG Trial 0539. October 2015.
12. Elson A, Bovi J, Siker M, Schultz C, Paulson E. Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma. J Neurooncol. 2015 May;122(3):549-58.
13. Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS. Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. J Neurooncol. 2015 May;123(1):179-88.
14. Brachman DG, Pugh SL, Ashby LS, Thomas TA, Dunbar EM, Narayan S, Robins HI, Bovi JA, Rockhill JK, Won M, Curran WP. Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. Int J Radiat Oncol Biol Phys. 2015 Apr 01;91(5):961-7. PMCID: PMC4706375
15. Elson A, Walker A, Bovi JA, Schultz C. Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting. Front Oncol. 2015;5:27. PMCID: PMC4321406
16. Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, Anscher MS, Bloom B, Mehta M. Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro Oncol. 2016 Apr;18(4):565-74. PMCID: PMC4799683
17. Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP. Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. J Clin Oncol. 2016 05 10;34(14):1620-5. PMCID: PMC4872318
18. Nguyen HS, Milbach N, Hurrell SL, Cochran E, Connelly J, Bovi JA, Schultz CJ, Mueller WM, Rand SD, Schmainda KM, LaViolette PS. Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma. AJNR Am J Neuroradiol. 2016 Dec;37(12):2201-2208. PMCID: PMC5161572
19. Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. J Neurosurg. 2018 Jul;129(1):35-47. PMCID: PMC5889346
20. BOVI, JA; Sparks, I; "Radiation Therapy in the Prevention of Brain Metastases". Medical Research Archives (5). (3). 3/2017.
21. McGarry, S, Hurrell, S, Kaczmarowski, A, Cochran, E, Connelly, J, BOVI, JA, Rand, S, Schmainda, K, Laviolette, P; Nimg-25. Radiomic Profiling Maps Areas Of Pathologically Confirmed Tumor And Predicts Overall Survival In Pre-Treatment Glioblastoma;  Neuro-Oncology 18(suppl_6):vi129-vi129 · November 2016
22. Prior P, Sparks I, Wilson JF, BOVI JA, Currey A, Bradley J, Kelly T, Li XA, White JR. Use of three dimensional conformal radiation therapy for node positive breast cancer does not result in excess lung and heart irradiation. Intl Jrnl of Med Physics, Clinical Engineering and Rad Onc, 2017;6:1-9
23. Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. J Neurosurg. 2018 07;129(1):35-47. PMCID: PMC5889346
24. Kidwell J, Schechter N, Michalski J, Shih, H, Strom E, Brown D, BOVI JA, Dominel M, Liu A, Mattes M, Wilkinson BJ, Harford AC, Tosenthal SE, Bradfield L, Kurth D, Rivers B, Rexrode S, Monzon B; "ACR–ASTRO Practice Parameter for Communication: Radiation Oncology"; Practice Parameter. 3/2018. Print.
25. Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA. Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. Neurosurgery. 2018 05 01;82(5):595-603.
26. Bovi JA, Schultz CJ, Mehta MP, Corn BW. Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order. Int J Radiat Oncol Biol Phys. 2018 09 01;102(1):59-60.
27. Bovi JA. Prevention of Brain Metastases. Front Neurol. 2018;9:758. PMCID: PMC6172309
28. Kruser, T.J., Bosch WR, Badiyan SN, BOVI JA, Ghia AJ, Kim MM, Solanki AA, Sachdev S, Tsien C, Wang TJC, Mehta MP, McMullen KP International Journal of Radiation Oncology, Biology, Physics , Volume 102 , Issue 3 , e351
29. BOVI, JA. "Expert Opinion: An Intracranial Hemorrhage Wrapped in an Enigma". International Journal of Radiation Oncology, Biology, Physics. ROB-D-19-00505. Print.
30. Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V, Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN, Moore KN, Huang J, Dominello MM, Kachnic LA. Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933 Advances in Radiation Oncology. 2019.
31. Bovi J. Unease With Uncertainty International Journal of Radiation Oncology Biology Physics. 1 October 2019;105(2):244-245.
32. BOVI, J. A. "Safety is No Accident" (Vol. 2). ASTRO. 2019. Chicago, IL.
33. Bovi J. Unease With Uncertainty. Int J Radiat Oncol Biol Phys. 2019 10 01;105(2):244-245.
34. Brown P, Gondi V, Pugh S, Bovi J, et al. "Cognitive preservation with hippocampal neural stem cell avoidance during whole-brain radiotherapy for brain metastases" Journal of Clinical Oncology (JCO). 10/2019. In Press.
35. Siker ML, Bovi J, Alexander B. Spinal Cord Tumors Clinical Radiation Oncology. 1 January 2015:521-540.e5.
36. Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V, Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN, Moore KN, Huang J, Dominello MM, Kachnic LA. Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933. Adv Radiat Oncol. 2019 Oct-Dec;4(4):579-586. PMCID: PMC6817553
37. Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, Kundapur V, Devisetty K, Shah S, Usuki K, Anderson BM, Stea B, Yoon H, Li J, Laack NN, Kruser TJ, Chmura SJ, Shi W, Deshmukh S, Mehta MP, Kachnic LA, for NRG Oncology. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. J Clin Oncol. 2020 Apr 01;38(10):1019-1029. PMCID: PMC7106984
38. Fisher BJ, Pugh SL, Macdonald DR, Chakravatri A, Lesser GJ, Fox S, Rogers CL, Werner-Wasik M, Doyle T, Bahary JP, Fiveash JB, Bovi JA, Howard SP, Michael Yu HH, D'Souza D, Laack NN, Barani IJ, Kwok Y, Wahl DR, Strasser JF, Won M, Mehta MP. Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):720-725. PMCID: PMC7456814
39. Palmer, J; Trifiletti, D; Gondi, V; Chan, M; Giuseppe, M; Rusthoven, C; Schild, S; Mishra, M; Bovi, J; Williams, N; Lustberg, M; Brown, P; Rao, Ganesh; Roberge, D; "Multidisciplinary Patient-Centered Management of Brain Metastases and Future Directions." Oxford University Press. Society for Neuro-Oncology. 2020.
40. Schechter NR, Brown DW, Bovi JA, Dominello MM, Liu AK, Mattes MD, Michalski JM, Shih HA, Strom E, Wilkinson JB, Rosenthal SA, Hartford A. ACR-ASTRO Practice Parameter for Communication: Radiation Oncology. Am J Clin Oncol. 2020 Aug;43(8):553-558.
41. Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ. Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes. Int J Radiat Oncol Biol Phys. 2020 Jun 27.
42. Tseng, C; Stewart, J; Whitfield, G; Verhoeff, J; Bovi, J; Soliman, H; Chung, C; Myrehaug, S; Campbell, M; Atenafu, E; Heyn, C; Das, S; Perry, J; Ruschin, M; Sahgal, A. "Glioma Consensus Contouring Recommendations from a MR-Linac International Consortium Research Group and Evaluation of a CT-MRI and MRI-Only Workflow. Journal of Neuro-Oncology. July 2020.
43. Bovi, J. "Glioma Consensus Contouring Recommendations from a MR-Linac International Consortium Research Group and Evaluation of a CT-MRI and MRI-Only Workflow" 8/2020. IN PRESS.
44. Bovi, J. "Low-Risk Meningioma: Outcomes from NRG Oncology/RTOG 0539" 8/2020. IN PRESS.
 
Books, Chapters, and Reviews
1. Schultz C, BOVI JA; Primary Central Nervous System Lymphoma, Chapter 98; In: Principles and Practice of Neuro-Oncology, A Multidisciplinary Approach. Mehta M, ed, New York, 2011 Demos Medical, pp 880-891.
2. Gore E, BOVI JA; Palliative Care in Thoracic Oncology. Handbook of Lung Cancer and Other Thoracic Malignancies, Kalemkerian G, Donington J, Gore E, and Ramalingam S ed, New York 2016 Demos Medical.
3. Bovi, J. “34, Spinal Cord Tumors.” Clinical Radiation Oncology, by Leonard L. Gunderson et al., Elsevier, 2016.
4. Bovi, J. “51, Spinal Cord Tumors.” Clinical Radiation Oncology, by Leonard L. Gunderson et al., Elsevier, 2018.
 
Abstracts
1. BOVI, JA, Melian, E, Siddiqui M. A Quantitative Comparison of CT Alone vs. CT/MR Image Fusion in Radiation Treatment Planning of Glioblastoma Multiforme: Is There Added Value with MR? Abstract #2055, ASTRO Annual Meeting 2002.
2. BOVI JA, Li XA, White J, Qi S. Comparison of 3 Partial Breast Irradiation Techniques: Treatment Effectiveness Based Upon Biological Models. Poster discussion abstract #1061, ASTRO Annual Meeting 2005.
3. BOVI JA, Rownd J, Lim H, White J. Toxicity and Cosmetic Outcome From Multi-Catheter Accelerated Partial Breast Irradiation in Early Stage Breast Cancer Patients. Abstract #4096, San Antonio Breast Cancer Symposium, 2006.
4. Sabsevitz D, BOVI JA, Leo P, LaViolette P, Rand S, Mueller W. Time Course and Risk Factors Associated with Whole-Brain Radiation Therapy (WBRT) Induced White Matter Damage: A Quantitative Study. Poster presentation at the 16th annual Society for Neuro-Oncology Conference, Orange County, CA, November 2011.
5. Currey A, Kelly T, BOVI JA, Rownd J, Morrow N, White J. The Importance of Three-Dimensional CT Treatment Planning to Optimize Outcomes from Accelerated Partial Breast Irradiation (APBI) with Brachytherapy in Early Stage Breast Cancer. Poster presented at the ASTRO 54th Annual Meeting, Boston, October 2012.
6. Brachman DG, Pugh SL, Ashby LS, Thomas TA, Dunbar EM, Narayan S, Robins HI, Bovi JA, Rockhill JK, Won M, Curran WP. Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. Int J Radiat Oncol Biol Phys. 2015 Apr 01;91(5):961-7. PMCID: PMC4706375
7. Elson A, BOVI JA, Kaur K, Maas D, Sinson G, Schultz C. Effect of Treatment Modality on the Hypothalamic-Pituitary Function of Patients Treated with Radiation Therapy for Pituitary Adenomas; Effect of Hypothalamic Dose on Endocrine Outcomes. Podium presentation at the 95th Annual Meeting of ARS, April 2013, Phoenix AZ
8. Leo PD, Franczak M, Berentsen S, BOVI JA, LaViolette PS, Schultz CJ, Sabsevitz DS. A Quantitative Study of Cerebral Atrophy Following Whole Brain Radiation Therapy. Poster presented at the 11th Annual Meeting of the American Academy of Clinical Neuropsychology, Chicago IL, June 2013.
9. Leo P, Franczak M, BOVI J, Sabsevitz D. Long Term Effects of Whole-Brain Radiation Therapy on Cerebral White Matter Injury. Poster presented at The International Neuropsychological Meeting, Seattle, WA 2014.
10. Elson A, BOVI, JA, Paulson E, Schultz C. Evaluation of The Pre-Radiotherapy Apparent Diffusion Coefficient (ADC): Patterns of Recurrence and Progression Free Survival Analysis in Patients Treated for GBM. poster presented at the 56th Annual Meeting of ASTRO, San Francisco, CA September 2014.
11. Straza MW, Freidland D, BOVI JA, Schultz C; "MS-25 GAMMA KNIFE RADIOSURGERY FOR VESTIBULAR SCHWANNOMA: ASSESSMENT OF QUALITY AND OUTCOMES", Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v132, https://doi.org/10.1093/neuonc/nou260.24
12. Mickevicius, N, Sabsevitz, D, BOVI, JA, LaViolette, PS. Effects of Whole Brain Radiation Therapy on Resting State Connectivity, A Case Study. Poster presented at the 56th Annual Meeting of ASTRO, San Francisco, CA September 2014.
13. BOVI JA, Prah M, Schultz C, Rand SD, Schmainda KM; "Treatment of Recurrent Glioblastoma with Bevacizumab with or without Reirradiation Using a Pulsed Low Dose Radiotherapy Technique: A Single Institution Experience" International Journal of Radiation Oncology. (90) (1) 9/2014. https://doi.org/10.1016/j.ijrobp.2014.05.978
14. Walker A, Elson A, BOVI JA; "Use of Helical Tomotherapy for Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting: A Single Institution Experience" San Francisco, CA September 2014.
15. Straza M, Garcia G, Hariri B, Patel R, Schultz C, Friedland D, BOVI JA; Gamma Knife Radiosurgery for Vestibular Schwannoma: Assessment of Quality and Outcomes. Poster presented at the Medical College of Wisconsin, Cancer Center Scientific Retreat, March 20, 2015. (MCWAH RESIDENT RESEARCH AWARD) Neuro-Oncology, Volume 16, Issue suppl_5, 1 November 2014, Pages v132, https://doi.org/10.1093/neuonc/nou260.24
16. Robinson C, Pugh S, Bovi J, Gondi V, Mehta M, Benzinger T, Owen C, Lo S, Kundapur V, Brown P, Sun A, Howard S, DeNittis A, Kachnic L; NCO-14 PRE-TREATMENT HIPPOCAMPAL VOLUME PREDICTS NEUROCOGNITIVE FUNCTION (NCF) FOR PATIENTS TREATED WITH HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIOTHERAPY (HA-WBRT) FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0933, Neuro-Oncology, Volume 17, Issue suppl_5, 1 November 2015, Pages v149, https://doi.org/10.1093/neuonc/nov223.14
17. Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby L, Modi J, Alleman A, Galvin JM, Brachman D, Jenrette JM, DeGroot J, BOVI, JA, Werner-Wasik M, Knisely JPS, Mehta MP. Intermediate-Risk Meningioma: Initial Outcomes from RTOG-0539. Oral presentation at the 57th Annual Meeting of ASTRO, San Antonio, TX October 18-21, 2015.
18. Zhang H, Zhang P, Gilbert M, Aldape K, Chakravarti A, Magliocco A, Klimowicz A, D'Souza W, Corn B, Hunter G, Muanza T, Dicker A, Vigneault E, Brachman D, BOVI, JA, Robins I, Sahijdak W, Won M, Mehta M. NRG Oncology/RTOG 0525 Role of Machine Learning Analytic Tools for Survival Prediction of GBM Patients Using Clinical Parameters. Oral presentation at the 57th Annual Meeting of ASTRO, San Antonio TX, October 18-21, 2015.
19. Botros M, Siker M, Schultz C, BOVI JA; Repeat Whole Brain Radiation Therapy Using a Pulsed Reduced Dose Rate Technique. Poster presented at the 57th Annual Meeting of ASTRO, San Antonio TX, October 18-21, 2015.
20. Saeed H, Cheng H, Kelly T, Wilson, JF, BOVI JA, White J, Currey A, Bergom C. Survival and Recurrence Patterns After 3D Conformal Radiotherapy for Whole Breast Irradiation in the Prone Position. Poster presented at the 57th Annual Meeting of ASTRO, San Antonio TX, October 18-21, 2015.
21. Saeed H, Cheng H, Kelly T, Wilson JF, BOVI JA, White J, Currey A, Bergom C. Toxicity and Cosmetic Outcome After Breast Conservation and Prone Whole-Breast Irradiation Using 3D Conformal Radiotherapy. Poster presented at the 57th Annual Meeting of ASTRO, San Antonio TX, October 18-21, 2015.
22. Robinson C, Pugh S, Bovi J, Gondi V, Mehta M, Benzinger T, Owen C, Lo S, Kundapur V, Brown P, Sun A, Howard S, DeNittis A, Kachnic L; NCO-14 PRE-TREATMENT HIPPOCAMPAL VOLUME PREDICTS NEUROCOGNITIVE FUNCTION (NCF) FOR PATIENTS TREATED WITH HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIOTHERAPY (HA-WBRT) FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0933, Neuro-Oncology, Volume 17, Issue suppl_5, 1 November 2015, Pages v149, https://doi.org/10.1093/neuonc/nov223.14
23. Robinson C, Pugh S, BOVI JA, Gondi V, Mehta M, Benzinger T, Lo S, Kundapur V, Brown P, Sun A, Howard S, DeNittis A, Kachnic L. Pre-Treatment Hippocampal Volume Predicts Neurocognitive Function (NCF) for Patients Treated with Hippocampal Avoidance Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases: Secondary analysis of NRG Oncology/RTOG 0933. Abstract #0121, 20th Annual Meeting of SNO, San Antonio TX, November 2015
24. Mehta M, Gondi V, Pugh S, Tome W, Wefel J, Fogh S, Movsas B, Konski A, Lassman A, Robinson C, BOVI JA, Benzinger T, Redmond K, Sun A, Bruner D. NRG CC003: Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer. Poster presented at the 5th Annual Brain Metastases Congress EORTC, Marseille France, October 2015.
25. Mehta M, Brown P, Pugh S, Gondi V, Wefel J, Tome W, Armstrong T, Robinson C, BOVI JA, Benzinger T, Grosshans D, Khuntia D, Konski A, Gilbert M, Bruner D. NRG CC001: Phase III trial Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients with Brain Metastases. Poster presented at the 5th Annual Brain Metastatic Congress EORTC, Marseille, France October 2015.
26. Zhang R, Vogelbaum MA, Perry A, Ashby L, Modi J, Alleman A, Galvin JM, Brachman D, Jenrette JM, DeGroot J, BOVI JA, Werner-Wasik M, Knisely JPS, Mehta M. Intermediate-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG-0539; 2015. Submitted for oral/poster presentation at the Society for NeuroOncology (SNO) First International Meeting on Meningioma, Toronto, Ontario, Canada, June 17-18, 2016.
27. Nguyen H. S., Milbach N., Hurrell S. L., Bovi J.A., et al. Progressing bevacizumab-induced diffusion restriction is associated with coagulative necrosis surrounded by viable tumor and decreased overall survival in patients with recurrent glioblastoma. American Journal of Neuroradiology. 2016;37(12):2201–2208. doi: 10.3174/ajnr.a4898.
28. Siker ML, Firat S, Prah D, Schultz CJ, Dayal A, Masterson C, Connelly JM, Mueller WM, BOVI JA; Pulsed Reduced Dose Rate Reirradiation (PRDR) Using Modulated Arc (mARC) Intensity Modulated Radiation Therapy for Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E125-E126.
29. Alleman, A, BOVI, JA, Chen, Y, Perry, A, Shrieve, D, Sneed, P, Vogelbaum, M, Zhang, P. Low-Risk Meningioma: Initial Outcomes from NRG Oncology RTOG 0539. Abstract # 13271, ASTRO Annual Meeting, September, 2016.
30. Rogers, L, Zhang, P, Vogelbaum, MA, Perry, A, Ashby, L, Modi, J, Alleman, A, Galvin, J, Youssef, E, BOVI, JA, Sneed, PK, McMillan, W, DeGroot, JF, Shrieve, D.C, Chen, Y, Shu, HKG, Chakravarti, A, Mehta, MP. Low-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG 0539, ASTRO 58th Annual Meeting, September, 2016
31. Prior PW Jr, Currey AD, Kelly TR, BOVI, JA, Bergom C, Li A. Dosimetric Feasibility of Preoperative Partial Breast Irradiation in Prone Position Using a Magnetic Resonance Linear Accelerator. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E691-E692.
32. Dayal A, Siker ML, Firat S, BOVI, JA, Schultz CJ, Mueller WM, Connelly JM, Rand SD. Clinical Significance of Updated MRI Simulation Versus Immediate Postoperative MRI for Radiation Treatment Planning in Patients With Glioblastoma: Changes in FLAIR Signal. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E103.
33. Rogers, L, Mehta, MP., Vogelbaum, MA, Zhang, P, Perry, A, Modi, J, Alleman, A, Galvin, J, Ashby, L, Youssef, E, BOVI, JA., Sneed, P. K, McMillan, W. DeGroot, J.F, Shrieve, D.C, Chen, Y, Shu, HKG, Chakravarti, WHO Grade I Patients Observed After Either Gross Total or Sub-Total Resection, ASTRO Late Breaking Abstract, RTOG-0539 Group, ASTRO 58th Annual Meeting, September, 2016
34. LaViolette P, Nguyen HS, BOVI, JA, Hurrell SA, Milbach N, Connelly J, Cochran E, Schmainda KM, & Rand SD. Progressive bevacizumab induced diffusion-restricted lesions indicate coagulative necrosis surrounded by non-enhancing tumor and are associated with decreased survival in recurrent glioblastoma patients. Annual meeting of the American Society for Neuroradiology (ASNR), Washington, DC. May 22nd 2016. Finalist for the Cornelius Dyke Award
35. Paulson, E, Eliason, A, Boyd, Z, Mickevicius, N, Prah, D, BOVI, JA; Brain MR-only using a Hybrid CT; International Journal of Radiatoin Oncology. (99)(2) 2/2017. https://doi.org/10.1016/j.ijrobp.2017.06.2309
36. Paulson, E, Eliason, BOVI, JA; Effect of Gadolinium on the Reversed Simulation Workflow in Brain; International Journal of Radiation Oncology. (99)(2). 2/2017. https://doi.org/10.1016/j.ijrobp.2017.06.2310
37. BOVI, JA, Pugh, S, Sabsevitz, D, Robinson, C, Paulson, E, Mehta, M, Gondi, V, Kundapur, V, Pinover, W, Chao, S, Machtay, M, DeNittis, A, Laack, N, Greenspoon, J, Mannel, R, Huang, J, Dominello, M, Kachnic, L; Pretreatment volume of MRI-determined white matter injury (WMI) predicts cognitive decline after hippocampal avoidant (HA) WBRT for brain metastases: Secondary analysis of NRG Oncology RTOG 0933; This project was supported by NCI grants U10CA180868, U10CA180822, U24CA180803, UG1CA189867; Presented SNO, November, 2017
38. Guignard VM, Kelm SE, Gillingham B, Firat SY, Prah D, Schultz C, Dayal A, Connelly J, Mueller W, BOVI JA, Siker ML; "Pulsed Reduced Dose Rate Re-Irradiation (PRDR) Using Modulated Arc (mARC) IMRT For Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique" International Journal of Radiation Oncology. (101) (2). 6/2018. https://doi.org/10.1016/j.ijrobp.2018.02.051
39. Kelm SE,Guignard VM, Botros ME,Gillingham BT, BOVI JA, Schultz CJ, Connelly J, Siker ML; "Repeat Whole Brain Radiation Therapy Using a Pulsed Reduced Dose Rate Technique" International Journal of Radiation Oncology. (93)(3). 11/2015. https://doi.org/10.1016/j.ijrobp.2015.07.800
40. Fleming J, Zhang P, Bell E, McElroy JP, Chang SM, Yousesef E, Hunter GK, Yung A, Anderson BM, BOVI JA, Bahary JP, Shih HA, Rabinovitch RA, Chen Y, Chakravarti A; "Elevated MGMT Gene Expression is Independently Associated with Worse Overall Survival in NRG Oncology/RTOG 9813: A Phase III Study of Radiation Therapy (RT) and Temozolomide (TMZ) Versus RT and Nitrosourea (NU) in Anaplastic Grade III Glioma (Astrocytoma Dominant)" International Journal of Radiation Oncology. (102)(3). 11/2018. https://doi.org/10.1016/j.ijrobp.2018.06.092
41. Bergom C, Jorns JM, Kelly T, BOVI JA, Kong A, Wadhwa A, Paulson E, Currey A; Characterization of Tumor Infiltrating Lymphocytes After Pre-Operative Accelerated Partial Breast Radiation Therapy in Favorable ER+ Breast Cancer Patients; ASTRO October, 2018; San Antonio, TX
42. Noid G, Currey A, Diane Schott, Tai A, Liu Y, Kelly TR, BOVI JA, Bergom C, Li XA; "Enhancement of CT Based Treatment Response Detection for Breast Cancer Using Dual-Energy CT" International Journal of Radiation Oncology. (102)(3). 11/2018. https://doi.org/10.1016/j.ijrobp.2018.06.190
43. Kruser T, Bosch W, Badiyan S, BOVI JA, Ghia A, Kim M, Sachdev S, Solanki A, Tsien C, Wang T, Meha M, McMullen K; "Consensus Radiotherapy Contouring Guidelines for Glioblastoma, Based on NRG Recommendations" International Journal of Radiation Oncology. Biology. Physics. 102. 3. 2018.
44. Bergom C, Jorns J, Kelly T, BOVI JA, Kong A, Wadhwa A, Paulson E, Currey A; Minimal Increases in Tumor Infiltrating Lymphocytes Despite Excellent Tumor Responses After Pre-Operative Accelerated Partial Breast Irradiation in Early Stage ER+ Breast Cancer Patients; ASTRO; Oral Presentation; San Antonio, TX; October, 2018
45. Gondi V, Deshmukh S, Brown PD, Wefel JS, Tome WA, Bruner DW, BOVI JA, Robinson CG, Khuntia D, Grosshans DR, Konski AA, Roberge D, Kundapur V, Devisetty K, Shah SA, Usaki KY, Anderson BM, Mehta MP, Kachnic LA; Preservation of Neurocognitive Function (NCF) with Conformal Avoidance of the Hippocampus during Whole-Brain Radiotherapy (HA-WBRT) for Brain Metastases: Preliminary Results of Phase III Trial NRG Oncology CC001; Abstract; ASTRO; San Antonio, TX; October, 2018
46. Chia-Lin Tseng, James Stewart, Mark Ruschin, Gillian Whitfield, Joost Verhoeff, Joseph Bovi, Hany Soliman, Caroline Chung, Sten Myrehaug, Mikki Campbell, Young K. Lee, Arjun Sahgal. "Variability in Expert Delineation of Targets and Organs-at-Risk in Gliomas for CT-MRI and MRI-Only Workflows" ASTRO, San Antonio, TX. 2018.
47. Fischer, B, Pugh, S, Macdonald, D, Chakravatri, A, Lesser, GL, Fox, S, Coons, SW, Rogers, CL, Werner-Wasik, M, Doyle, T, Bahary, JP, Fiveash, JB, Bovi, JA, Howard, SP, Yu, HHM, D'Souza, D, Laack, NN, Roach, M, Kwok, Y, Wahl, DR, Strasser, JF, Won, M, Mehta, MP. "NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS". Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi11, https://doi.org/10.1093/neuonc/noy148.039
48. BOVI, JA. "NRG Oncology CC003: A randomized phase II/III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small cell lung cancer". TPS8578. 6/2/2019. DOI: 10.1200/JCO.2019.37.15_suppl.TPS8578 Journal of Clinical Oncology 37, no. 15_suppl
49. Lynch C, Hartsell W F, Chang J C H, Sweeney P J, Kalapurakal J A, Diaz A Z, Chandler J P, Tsung A J, Prabhu V, BOVI, J A., Connelly M, Grimm S, Raizer S, Sarma K, Conterato D J, Rajendran Jr R R, and Gondi V; Toxicity, Disease Control, and Survival Following Proton Therapy Fractionated Re-Irradiation for Recurrent Intracranial Meningioma Not Amenable to Radiosurgery. ASTRO. Chicago, IL. 9/2019.
50. Bovi, JA. "NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-brain Radiotherapy (WBRT) Plus memantine to Preserve Neurocognitive Function (NCF) in Patients with Brain Metastases (BM)." Journal of Clinical Oncology 37. 15. 5/2019. Print DOI: 10.1200/JCO.2019.37.15_suppl.2009
51. Desai N, Jorns J, Kelly T, Bovi J, "Correlation Between Tumor Infiltrating Lymphocytes and 21-Gene Recurrence Score in Patients Undergoing Pre-Operative Accelerated Partial Breast Irradiation" ASTRO 2019. Chicago, IL.
52. 43. Gondi V, Deshmukh S, Brown PD, Wefel JS, Tome WA, Bruner DW, BOVI JA, Robinson CG, Khuntia D, Grosshans DR, Konski AA, Roberge D, Kundapur V, Devisetty K, Shah SA, Usaki KY, Anderson BM, Mehta MP, Kachnic LA; Preservation of Neurocognitive Function (NCF) with Conformal Avoidance of the Hippocampus during Whole-Brain Radiotherapy (HA-WBRT) for Brain Metastases: Preliminary Results of Phase III Trial NRG Oncology CC001; Abstract; ASTRO; San Antonio, TX; October, 2018
53. Bovi, J. "ACR–ASTRO Practice Parameter for Communication: Radiation Oncology" American Journal of Clinical Oncology (AJCO) 2/2020.
54. Bovi, J., Curtis, T., Lindstedt, J., Brausch, C., Blissitt, J., Crabb, M., Erlitz, T., Gottschalk, J., Leuck, J., Nelson, A., Meerstein, H., Mueller, W., Peltier, W., Presser, C., Richardson, K., Santos-Pinheiro, F., Thompson, J., Roller-Voigt, K., Atkinson, D., Schultz, C. "Integrated Management of Brain Metastases" 2020 Vizient Connections Education Summit. 2/2020.
55. Straza, M., Bovi, J., Puckett, L., Siker, M., Saeed, H., Ahunbay, E., Chen, Y., Mueller, W., Santos-Pinheiro, F., Connelly, J., Hall, W., Li, A., Schultz, C., Paulson, E., "Quantitative Imaging of Patients Undergoing Radiotherapy for Primary Gliomas Using A 1.5 Tesla MR Linac" 2/2020.
56. Rogers, L; Bovi, J; "NRG/TROG 0539 Combined Group Analysis" 2020.
57. Rogers, L; Pugh, S; Vogelbaum, M; Perry, A; Ashby, L; Modi, J; Alleman, A; Youssef, E; Braunstein, S; Bovi, J; de Groot, J; Whitton, A; Lindhorst, S; Taylor, N; Shrieve, D; Shu, HK; Machtav, M; Mishra, M; Robinson, C; Mehta, M. "Low-Risk Meningioma: Outcomes from NRG Oncology/RTOG 0539". SNO 2020. Presented Abstract.
58. Bovi, J. "Pretreatment volume of MR-determined white matter injury(WMI) predicts neurocognitive decline after hippocampal avoidant(HA)WBRT+Memantine for brain metastases: Secondary analysis of NRG OncologyCC001" 8/2020.
 

jenkins-FCD Prod-478 d1509cf07a111124a2d122fd3df854cc0b993c00